- Home
- IMTX vs RAPP Comparison
IMTX vs RAPP Comparison
Compare IMTX & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMTX | RAPP |
|---|---|---|
| Founded | N/A | 2022 |
| Country | Germany | United States |
| Employees | 423 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | IMTX | RAPP |
|---|---|---|
| Price | $9.50 | $28.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $19.25 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 447.4K | 317.4K |
| Earning Date | 01-01-0001 | 06-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.34 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.92 | N/A |
| Revenue Next Year | $15.88 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.30 | $7.73 |
| 52 Week High | $12.41 | $42.27 |
Technical Indicators
Market Signals| Indicator | IMTX | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 45.78 |
| Support Level | $8.72 | $25.40 |
| Resistance Level | $10.64 | $29.84 |
| Average True Range (ATR) | 0.56 | 1.99 |
| MACD | -0.07 | -0.13 |
| Stochastic Oscillator | 19.93 | 30.69 |
Price Performance
Historical ComparisonAbout IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About RAPP Rapport Therapeutics Inc.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.